• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NCI-H660前列腺癌细胞系中TMPRSS2-ERG基因融合的分子特征:旧模型的新视角

Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

作者信息

Mertz Kirsten D, Setlur Sunita R, Dhanasekaran Saravana M, Demichelis Francesca, Perner Sven, Tomlins Scott, Tchinda Joëlle, Laxman Bharathi, Vessella Robert L, Beroukhim Rameen, Lee Charles, Chinnaiyan Arul M, Rubin Mark A

机构信息

Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115-6110, USA.

出版信息

Neoplasia. 2007 Mar;9(3):200-6. doi: 10.1593/neo.07103.

DOI:10.1593/neo.07103
PMID:17401460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1838578/
Abstract

Recent studies have established that a significant fraction of prostate cancers harbor a signature gene fusion between the 5' region of androgen-regulated TMPRSS2 and an ETS family transcription factor, most commonly ERG. Studies on the molecular mechanisms and functional consequences of this important chromosomal rearrangement are currently limited to the VCaP cell line derived from a vertebral bone metastasis of a hormone-refractory prostate tumor. Here we report on the NCI-H660 cell line, derived from a metastatic site of an extrapulmonary small cell carcinoma arising from the prostate. NCI-H660 harbors TMPRSS2-ERG fusion with a homozygous intronic deletion between TMPRSS2 and ERG. We demonstrate this by real-time quantitative polymerase chain reaction, a two-stage dual-color interphase fluorescence in situ hybridization (FISH) assay testing for TMPRSS2 and ERG break-aparts, and single-nucleotide polymorphism oligonucleotide arrays. The deletion is consistent with the common intronic deletion found on chromosome 21q22.2-3 in human prostate cancer samples. We demonstrate the physical juxtaposition of TMPRSS2 and ERG on the DNA level by fiber FISH. The androgen receptor-negative NCI-H660 cell line expresses ERG in an androgen-independent fashion. This in vitro model system has the potential to provide important pathobiologic insights into TMPRSS2-ERG fusion prostate cancer.

摘要

近期研究表明,相当一部分前列腺癌存在雄激素调节的跨膜丝氨酸蛋白酶2(TMPRSS2)5'区域与ETS家族转录因子(最常见的是ERG)之间的特征性基因融合。目前,关于这种重要染色体重排的分子机制和功能后果的研究仅限于源自激素难治性前列腺肿瘤椎体骨转移的VCaP细胞系。在此,我们报告了NCI-H660细胞系,它源自前列腺来源的肺外小细胞癌的转移部位。NCI-H660存在TMPRSS2-ERG融合,且TMPRSS2和ERG之间存在纯合内含子缺失。我们通过实时定量聚合酶链反应、检测TMPRSS2和ERG断裂分离的两阶段双色间期荧光原位杂交(FISH)分析以及单核苷酸多态性寡核苷酸阵列来证实这一点。该缺失与人类前列腺癌样本中21q22.2-3染色体上常见的内含子缺失一致。我们通过纤维FISH在DNA水平上证明了TMPRSS2和ERG的物理并列。雄激素受体阴性的NCI-H660细胞系以雄激素非依赖方式表达ERG。这个体外模型系统有可能为TMPRSS2-ERG融合前列腺癌提供重要的病理生物学见解。

相似文献

1
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.NCI-H660前列腺癌细胞系中TMPRSS2-ERG基因融合的分子特征:旧模型的新视角
Neoplasia. 2007 Mar;9(3):200-6. doi: 10.1593/neo.07103.
2
Morphological features of TMPRSS2-ERG gene fusion prostate cancer.TMPRSS2-ERG基因融合前列腺癌的形态学特征。
J Pathol. 2007 May;212(1):91-101. doi: 10.1002/path.2154.
3
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.通过易位或间质性缺失形成的TMPRSS2:ERG融合在雄激素依赖性前列腺癌中高度相关,但在晚期雄激素受体阴性前列腺癌中则不存在。
Cancer Res. 2006 Nov 15;66(22):10658-63. doi: 10.1158/0008-5472.CAN-06-1871.
4
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.前列腺癌男性尿液中TMPRSS2:ERG融合转录本的无创检测
Neoplasia. 2006 Oct;8(10):885-8. doi: 10.1593/neo.06625.
5
TMPRSS2:ETS fusions and clinicopathologic characteristics of prostate cancer patients from Eastern China.中国东部前列腺癌患者的TMPRSS2:ETS融合与临床病理特征
Asian Pac J Cancer Prev. 2014;15(7):3099-103. doi: 10.7314/apjcp.2014.15.7.3099.
6
A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer.一种用于检测前列腺癌中TMPRSS2和ERG重排的新型四色荧光原位杂交检测方法。
Cancer Genet. 2013 Jan-Feb;206(1-2):1-11. doi: 10.1016/j.cancergen.2012.12.004. Epub 2013 Jan 24.
7
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.前列腺癌中TMPRSS2与致癌性ETS因子的融合涉及基因组重排失衡,并与HDAC1及表观遗传重编程相关。
Cancer Res. 2006 Nov 1;66(21):10242-6. doi: 10.1158/0008-5472.CAN-06-1986.
8
Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.雄激素非依赖性转移性前列腺癌中TMPRSS2-ETS基因畸变的特征分析
Cancer Res. 2008 May 15;68(10):3584-90. doi: 10.1158/0008-5472.CAN-07-6154.
9
Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.前列腺癌中TMPRSS2/ERG融合的三色荧光原位杂交分析表明,21号染色体的基因组微缺失与重排有关。
Neoplasia. 2006 Jun;8(6):465-9. doi: 10.1593/neo.06283.
10
Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues.前列腺癌中TMPRSS2与ETS家族基因之间的基因融合:通过对石蜡包埋组织进行RT-PCR和FISH分析其频率及转录本变体
Mod Pathol. 2007 Sep;20(9):921-8. doi: 10.1038/modpathol.3800903. Epub 2007 Jul 13.

引用本文的文献

1
A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma.一种用于评估神经内分泌前列腺癌向前列腺腺癌可逆性的高灵敏度筛查系统。
Cancer Med. 2025 Mar;14(5):e70047. doi: 10.1002/cam4.70047.
2
AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer.雄激素受体(AR)与Yes相关蛋白(YAP)的相互作用:对前列腺癌治疗策略的影响
Front Oncol. 2025 Feb 3;15:1520808. doi: 10.3389/fonc.2025.1520808. eCollection 2025.
3
Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers.了解 Pax5 在多西紫杉醇耐药神经内分泌样前列腺癌发展中的作用。
Cell Death Dis. 2024 Aug 25;15(8):617. doi: 10.1038/s41419-024-06916-y.
4
ENO2, a Glycolytic Enzyme, Contributes to Prostate Cancer Metastasis: A Systematic Review of Literature.糖酵解酶ENO2促进前列腺癌转移:文献系统综述
Cancers (Basel). 2024 Jul 10;16(14):2503. doi: 10.3390/cancers16142503.
5
Understanding the role of Pax5 in development of taxane-resistant neuroendocrine like prostate cancers.了解Pax5在紫杉烷耐药性神经内分泌样前列腺癌发展中的作用。
Res Sq. 2023 Dec 11:rs.3.rs-3464475. doi: 10.21203/rs.3.rs-3464475/v1.
6
Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression.FAM3B 与雄激素受体之间反馈调节的丧失驱动前列腺癌的进展。
J Natl Cancer Inst. 2024 Mar 7;116(3):421-433. doi: 10.1093/jnci/djad215.
7
Three Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System.受内分泌系统调节的内分泌器官和靶组织的三维模型。
Cancers (Basel). 2023 Sep 17;15(18):4601. doi: 10.3390/cancers15184601.
8
Fusion sequencing via terminator-assisted synthesis (FTAS-seq) identifies TMPRSS2 fusion partners in prostate cancer.融合测序通过终结者辅助合成(FTAS-seq)鉴定前列腺癌中的 TMPRSS2 融合伙伴。
Mol Oncol. 2023 Jun;17(6):993-1006. doi: 10.1002/1878-0261.13428. Epub 2023 Apr 13.
9
Minor intron splicing is critical for survival of lethal prostate cancer.小内含子剪接对致命前列腺癌的存活至关重要。
Mol Cell. 2023 Jun 15;83(12):1983-2002.e11. doi: 10.1016/j.molcel.2023.05.017. Epub 2023 Jun 8.
10
Fusion Genes in Prostate Cancer: A Comparison in Men of African and European Descent.前列腺癌中的融合基因:非洲裔和欧洲裔男性的比较。
Biology (Basel). 2022 Apr 20;11(5):625. doi: 10.3390/biology11050625.

本文引用的文献

1
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.TMPRSS2:ERG基因融合与观察等待队列中致命性前列腺癌相关。
Oncogene. 2007 Jul 5;26(31):4596-9. doi: 10.1038/sj.onc.1210237. Epub 2007 Jan 22.
2
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.通过易位或间质性缺失形成的TMPRSS2:ERG融合在雄激素依赖性前列腺癌中高度相关,但在晚期雄激素受体阴性前列腺癌中则不存在。
Cancer Res. 2006 Nov 15;66(22):10658-63. doi: 10.1158/0008-5472.CAN-06-1871.
3
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate.人类前列腺中TMPRSS2-ERG融合转录本的多样性。
Oncogene. 2007 Apr 19;26(18):2667-73. doi: 10.1038/sj.onc.1210070. Epub 2006 Oct 16.
4
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer.变异型TMPRSS2/ERG融合信使核糖核酸的表达与侵袭性前列腺癌相关。
Cancer Res. 2006 Sep 1;66(17):8347-51. doi: 10.1158/0008-5472.CAN-06-1966.
5
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.TMPRSS2:ERG融合相关缺失为深入了解前列腺癌的异质性提供了线索。
Cancer Res. 2006 Sep 1;66(17):8337-41. doi: 10.1158/0008-5472.CAN-06-1482.
6
Prognostic factors in lymph node-positive prostate cancer.淋巴结阳性前列腺癌的预后因素
Urology. 2006 May;67(5):1016-21. doi: 10.1016/j.urology.2005.10.055.
7
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.TMPRSS2:ETV4基因融合定义了前列腺癌的第三种分子亚型。
Cancer Res. 2006 Apr 1;66(7):3396-400. doi: 10.1158/0008-5472.CAN-06-0168.
8
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.前列腺癌中TMPRSS2与ETS转录因子基因的反复融合
Science. 2005 Oct 28;310(5748):644-8. doi: 10.1126/science.1117679.
9
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.雄激素非依赖性前列腺癌是一组异质性疾病:快速尸检项目的经验教训。
Cancer Res. 2004 Dec 15;64(24):9209-16. doi: 10.1158/0008-5472.CAN-04-2442.
10
Detection of large-scale variation in the human genome.人类基因组中大规模变异的检测。
Nat Genet. 2004 Sep;36(9):949-51. doi: 10.1038/ng1416. Epub 2004 Aug 1.